Real-World Survival and Treatment Regimens Across First- to Third-Line Treatment for Advanced Triple-Negative Breast Cancer

BACKGROUND: Metastatic triple-negative breast cancer (mTNBC) is an aggressive subtype of breast cancer with poor survival. Currently, the literature lacks comprehensive real-world evidence on locally recurrent and mTNBC patients. To validate the optimal treatment for patients with mTNBC, real-world...

Descripción completa

Detalles Bibliográficos
Autores principales: Celik, Alan, Berg, Tobias, Jensen, Maj-Britt, Jakobsen, Erik, Nielsen, Hanne Melgaard, Kümler, Iben, Glavicic, Vesna, Jensen, Jeanette Dupont, Knoop, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552450/
https://www.ncbi.nlm.nih.gov/pubmed/37810797
http://dx.doi.org/10.1177/11782234231203292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552450/
https://www.ncbi.nlm.nih.gov/pubmed/37810797
http://dx.doi.org/10.1177/11782234231203292

Ejemplares similares